📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
10
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GNE.
💹 Market Data
Market Cap$373.08M
Shares Outstanding24.83M
Float20.23M
Cash$194.85M
Debt$8.63M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 0.6% shares (2025Q4 vs prior)
116 institutional holders · 10.17M shares
#1
BlackRock, Inc.
2.17M shares
#2
VANGUARD GROUP INC
1.20M shares
#3
DIMENSIONAL FUND ADVISORS LP
898.5K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest446.0K
Days to Cover8.7
% of Float2.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Mar 31, 2022
4
INSIDER TRANSACTION
Feb 12, 2026
4
INSIDER TRANSACTION
Feb 12, 2026
4
INSIDER TRANSACTION
Feb 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GNE
📊 GNE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GNE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.